Matthew Lawrence

A panel of 7 people of different races and genders sitting at a table

Fascinating(yet depressing) plenary session at the Health Law Professors Conference ft. @ninakohn.bsky.social @mayamanian.bsky.social @mblawrence.bsky.social Medha Makhlouf Joan Krause Aaron Kessleheim: Updates on healthcare law & policy in tumultuous times. #HLP2025

I always like to see what other LPE and LPE Adjacent Scholars are up to. Thanks to @lpeblog.bsky.social for highlighting my article alongside other people whom I like reading such as @mblawrence.bsky.social, Bijal Shah, and Fred Jacobs, amongst others.

"Within only a couple months, Sewell became addicted to the app."

Big decision denying motion to dismiss on 1A grounds today in Garcia v. Character A.I., the first case against a chatbot for allegedly contributing to a teen's death.

Full opinion here: tinyurl.com/496s4epn

My book won the 2025 Neustadt award for best book on the American presidency.

Presidents enact bad policies, on purpose, because it helps them define their brand & gives the impression they're in charge. If that basic message resonates, please give it some of your reading time: lnkd.in/dVPsriXt

Surreal honor to be among a truly impressive list of experts recently appointed to serve as public members and senior fellows of the Administrative Conference of the United States. www.acus.gov/article/admi...

Thank you to the wonderful editors of the Indiana Law Journal for bringing "Super-Groups: Legal Empowerment and Public Law" to print!

My best effort to explore who the "powerful" are and the role of law in making them that way.

www.repository.law.indiana.edu/ilj/vol100/i...

Within 30 days of the date of this order, the Secretary shall, in coordination with the Assistant to the President for Domestic Policy, the Administrator for the Centers for Medicare and Medicaid Services, and other relevant executive department and agency (agency) officials, communicate most-favored-nation price targets to pharmaceutical manufacturers to bring prices for American patients in line with comparably developed nations.

There's relatively little substantive content in the text of the MFN EO, but this section is emblematic of the many, many questions people should have about its scope. Where will the Secretary get this pricing information? How will they decide "price targets"? For which drugs? Which countries? Etc.

Sharing some of my thoughts on the unconstitutionality of impoundment at @dorfonlaw.bsky.social

Thoughts welcome!

Thanks Josh!

Thank you!

"in effect the early second Trump Administration seems to have substituted OMB’s legal authority over apportionment (which now must be exercised transparently) with DOGE’s functional control over federal payment systems"

www.yalejreg.com/nc/secret-co...

Great piece on by @mblawrence.bsky.social

Very cool-looking new paper from Dave Pozen and @mblawrence.bsky.social. Check it out! papers.ssrn.com/sol3/papers....

Thanks @gaiabernstein.bsky.social and Seattle L. Rev.!

Aspects of social media regulation we address:
1. Is "addiction" the right word?
2. Epistemic bias and how it distorts the conversation
3. How industry bends science
4. Do we consent to being conditioned?
5. The costs of phone bans
6. Some ways kids are different

Incredible to see "Moral Panic or Public Health Crisis? Lessons From Drugs and Gambling for 'Addictive' Design" now out in print!

With my amazing @EmoryLaw 2L coauthor, Kevin Yan.

When was the last time you saw a Music Man epigraph?

digitalcommons.law.seattleu.edu/cgi/viewcont...

Doing our best to explain what is going on with checks and balances when it comes to federal spending!

Over at the Notice and Comment blog, today's Ad Law Reading Room entry is "Appropriations Presidentialism," by @mblawrence.bsky.social, Eloise Pasachoff, and Zachary Price. Check it out! www.yalejreg.com/nc/ad-law-re...

"'Appropriations Presidentialism'—which clocks in at an eminently readable 25 pages—is both a short and engaging introduction to the issues and an extremely thoughtful preliminary assessment of an important development."

Thanks @dtdeacon.bsky.social for sharing our paper in the Ad Law Reading Room!

Excited to have the opportunity to present Statutory Liquidation at the Harvard/Yale/Stanford Junior Faculty Forum in June! Check the paper out here: papers.ssrn.com/sol3/papers....

missed this amid *gestures* last week, but this is such a fantastic, fascinating read. I learned a ton and saw countless ways these systems (and their shortcomings) had affected my own access to essential medications, others' challenges finding care, and much else.

so, so well worth your time.

Thank you!

Thanks Ben!

Thanks Mason!

With marijuana rescheduling stalled, and tighter control of other substances on the horizon, analyzing drug scheduling is timely & closely linked to public health.

Read an insightful piece from @mblawrence.bsky.social & David Pozen, forthcoming in Harvard L. Rev.

papers.ssrn.com/sol3/papers....

This paper is excellent — a must-read for anybody concerned by the failures of our federal drug scheduling system, and how to fix it.

And thanks very much to several helpful commenters, including @rachelbarkow.bsky.social @benjaminabarsky.bsky.social @masonmarks.bsky.social @nbagley.bsky.social. More thoughts and comments very welcome!

Pozen and I explain how "the three Ps" have undermined the CSA. And we offer proposals to expand drug access and reduce drug harms, without opening the door to extractive capitalism.

Drug law meets admin law meets public health meets harm reduction meets LPE.

Marijuana rescheduling has stalled. The Controlled Substances Act has failed. The opioid crisis continues.

We need to rethink drug scheduling from the ground up. But how?

Excited to share Dave Pozen's and my effort, forthcoming in the Harvard Law Review. tinyurl.com/3cxe6bh6

Thread: this flew under the radar but is very concerning. Apportionment involves pro-forma OMB quarterly letters to agencies confirming they can spend $ as appropriated by Congress. OMB has now permanently shuttered the public apportionment website per Politico/letter from OMB to Senator Murray.

Now that courts are pushing back on DOGE's interference with spending through Treasury systems, OMB is breaking the law to keep its own spending actions secret.

I explain this separation of powers struggle in "Secret Conditions Move from DOGE to OMB," just up at Yale J Reg. tinyurl.com/3uyht563